Bea
Bea Langton-Webster, Woodinville, WA US
Patent application number | Description | Published |
---|---|---|
20140241985 | Chelated PSMA Inhibitors - Compounds as defined herein are provided which are useful in (1) diagnostic methods for detecting and/or identifying cells presenting PSMA; (2) compositions comprising a compound of the invention together with a pharmaceutically acceptable diluent; and (3) methods for imaging prostate cancer cells. | 08-28-2014 |
Bea Mézes, Budapest HU
Patent application number | Description | Published |
---|---|---|
20100267711 | METHOD OF ENHANCING CELLULAR PRODUCTION OF MOLECULAR CHAPERONE, HYDROXYLAMINE DERIVATIVES USEFUL FOR ENHANCING THE CHAPERONE PRODUCTION AND THE PREPARATION THEREOF - A method of increasing expression of a molecular chaperon by a cell and/or enhancing the activity of a molecular chaperon in cells is provided. The method comprises treating a cell that is exposed to a physiological stress which induces expression of a molecular chaperon by the cell with an effective amount of a certain hydroxylamine derivative to increase the stress. Alternatively, an hydroxylamine derivative can be administrated to a cell before it is exposed to a physiological stress which induces expression of a molecular chaperon by the cell. Preferably, the cell to which an hydroxylamine derivative is administered is an eukaryotic cell. The hydroxylamine derivative corresponds to the formulae (I) or (II). | 10-21-2010 |
Bea Mézes, Budapest HU
Patent application number | Description | Published |
---|---|---|
20100267711 | METHOD OF ENHANCING CELLULAR PRODUCTION OF MOLECULAR CHAPERONE, HYDROXYLAMINE DERIVATIVES USEFUL FOR ENHANCING THE CHAPERONE PRODUCTION AND THE PREPARATION THEREOF - A method of increasing expression of a molecular chaperon by a cell and/or enhancing the activity of a molecular chaperon in cells is provided. The method comprises treating a cell that is exposed to a physiological stress which induces expression of a molecular chaperon by the cell with an effective amount of a certain hydroxylamine derivative to increase the stress. Alternatively, an hydroxylamine derivative can be administrated to a cell before it is exposed to a physiological stress which induces expression of a molecular chaperon by the cell. Preferably, the cell to which an hydroxylamine derivative is administered is an eukaryotic cell. The hydroxylamine derivative corresponds to the formulae (I) or (II). | 10-21-2010 |
Bea Yu, Lexington, MA US
Patent application number | Description | Published |
---|---|---|
20150112232 | USING CORRELATION STRUCTURE OF SPEECH DYNAMICS TO DETECT NEUROLOGICAL CHANGES - A method and a system for assessing a condition in a subject. An example of a condition is a Major Depressive Disorder (MDD). The method comprises measuring at least one speech-related variable in a subject; extracting a channel-delay correlation structure of the at least one speech-related variable; and generating an assessment of a condition of the subject, based on the correlation structure of the at least one speech-related variable. | 04-23-2015 |